Close Menu

NEW YORK – While the COVID-19 pandemic upended and disrupted life throughout the globe, the crisis had an overwhelmingly bullish effect on the stocks of many diagnostics companies in 2020.

For 2020, the 360Dx Index grew by nearly 31 percent year over year, outpacing the Dow Jones Industrial Average, which grew by 7 percent in 2020, and the Nasdaq Biotech Index, which increased by 26 percent. The Nasdaq Composite was up nearly 44 percent in 2020.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.